{"database": "lobbying", "table": "lobbying_activities", "rows": [[3806469, "92fbb00f-0ece-4e1b-9b61-316cb11d2bc3", "Q1", "IPOLICY SOLUTIONS", 401105127, "GUARDANT HEALTH INC.", 2026, "first_quarter", "MED", "FDA-2025-N-4622 Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use with a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order", "Food & Drug Administration (FDA)", 16000, null, 0, 0, "2026-04-13T13:58:10-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3806469"], "units": {}, "query_ms": 0.3343639837112278, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}